|
The Vioxx debacle might finally be over and with some possible positive side-effects. Merck has agreed to pay $4.85 billion to plaintiffs. Merck won most of the trials that did make it to juries, which should encourage pharm execs with fingers on the development trigger. And, though the $4.85 billion almost...
Aren't you a subscriber?
This area is only available to paid subscribers. Please login below with your username and password.
If you would like more information on subscribing, click here.
|
- Questex Broadens Digital Reach — August 25, 2008
- Community, Mobile and Oh-So-Much Unused Data — June 2, 2008
- Custom Pub Gives Conferences Long Legs, Added Value — August 25, 2008
- Advertisers Stick With Circuit Cellar's Focused Niche — August 25, 2008
|
